Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 14, 2024Frontiers in PsychiatryOpen Access

Evaluating the rate of reversal of fentanyl-induced respiratory depression using a novel long-acting naloxone nanoparticle, cNLX-NP

View Full Paper
Ask AI
Bookmark
Share

Authors

SASaadyah AverickAmerican Health NetworkAKAndrew J. KassickBioHybrid Solutions (United States)DSDaihyun SongUniversity of Minnesota System

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Averick et al. (2024) studied this question.

synapsesocial.com/papers/68e73ff3b6db6435876b9d72https://doi.org/10.3389/fpsyt.2024.1366186
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1In Vitro and In Vivo Evaluations of PLGA Microspheres Containing Nalmefene2015 · 33 citations
  2. 2Asphyxiation with a Fentanyl Patch2013 · 36 citations
  3. 3Degradation rates of oral resorbable implants (polylactates and polyglycolates): Rate modification with changes in PLA/PGA copolymer ratios1977 · 716 citations
  4. 4Higher naloxone dosing may be required for opioid overdose2019 · 27 citations
  5. 5Covalently Loaded Naloxone Nanoparticles as a Long-Acting Medical Countermeasure to Opioid Poisoning2021 · 21 citations